These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25758228)

  • 1. Staphylococcus aureus sepsis in rheumatoid arthritis.
    Sams M; Olsen MA; Joshi R; Ranganathan P
    Rheumatol Int; 2015 Sep; 35(9):1503-10. PubMed ID: 25758228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy.
    Goodman SM; Nocon AA; Selemon NA; Shopsin B; Fulmer Y; Decker ME; Grond SE; Donlin LT; Figgie MP; Sculco TP; Russell LA; Henry ME; Bass AR; Miller AO; Sculco PK
    J Arthroplasty; 2019 May; 34(5):954-958. PubMed ID: 30733073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment.
    Bassetti S; Wasmer S; Hasler P; Vogt T; Nogarth D; Frei R; Widmer AF
    J Rheumatol; 2005 Nov; 32(11):2125-9. PubMed ID: 16265689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus bacteremia in patients with rheumatoid arthritis - Data from the prospective INSTINCT cohort.
    Joost I; Kaasch A; Pausch C; Peyerl-Hoffmann G; Schneider C; Voll RE; Seifert H; Kern WV; Rieg S
    J Infect; 2017 Jun; 74(6):575-584. PubMed ID: 28322887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
    Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
    Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
    Bernatsky S; Hudson M; Suissa S
    Rheumatology (Oxford); 2005 May; 44(5):677-80. PubMed ID: 15784627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.
    Pieringer H; Hintenberger R; Pohanka E; Steinwender C; Meier J; Gruber F; Auer-Hackenberg L
    Clin Rheumatol; 2017 Nov; 36(11):2439-2445. PubMed ID: 28905133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
    Kawashima H; Kagami SI; Kashiwakuma D; Takahashi K; Yokota M; Furuta S; Iwamoto I
    Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
    Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR
    Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
    Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
    Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs.
    Momohara S; Kawakami K; Iwamoto T; Yano K; Sakuma Y; Hiroshima R; Imamura H; Masuda I; Tokita A; Ikari K
    Mod Rheumatol; 2011 Oct; 21(5):469-75. PubMed ID: 21318306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis and aggravation of arthritis in a rheumatoid arthritis patient as a result of sepsis due to Staphylococcus aureus infection of a rheumatoid nodule; a catastrophic outcome.
    Saito H; Miyata M; Ito M; Katakura K; Shishido H; Orikasa H; Munakata O; Saka M; Nishimaki T; Uchiyama T; Kasukawa R
    Fukushima J Med Sci; 1999 Dec; 45(2):125-33. PubMed ID: 11039609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.
    Suissa S; Ernst P; Hudson M; Bitton A; Kezouh A
    Am J Med; 2004 Jul; 117(2):87-92. PubMed ID: 15234643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis.
    Richter A; Listing J; Schneider M; Klopsch T; Kapelle A; Kaufmann J; Zink A; Strangfeld A
    Ann Rheum Dis; 2016 Sep; 75(9):1667-73. PubMed ID: 26567181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.
    Rodriguez-Rodriguez L; Leon L; Ivorra-Cortes J; Gómez A; Lamas JR; Pato E; Jover JÁ; Abásolo L
    Clin Exp Rheumatol; 2016; 34(6):1026-1032. PubMed ID: 27749239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antirheumatic treatment, disease activity and risk of
    Dieperink SS; Mehnert F; Nørgaard M; Oestergaard LB; Benfield T; Petersen A; Torp-Pedersen C; Glintborg B; Hetland ML
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36517186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral staphylococcus in older subjects with rheumatoid arthritis.
    Jacobson JJ; Patel B; Asher G; Woolliscroft JO; Schaberg D
    J Am Geriatr Soc; 1997 May; 45(5):590-3. PubMed ID: 9158580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.